First Percutaneous Pump Approved for Right Heart Failure

The Impella RP device was approved by the FDA for use as a temporary percutaneous assist for  the right ventricle, as announced by Abiomed.  Use is approved for up to 14 days for a variety of indications including post MI, heart transplant, open heart surgery, or right heart failure after LVAD implant.